SCHEMBL3891306

SCHEMBL3891306

NC(Cc1ccc(O)cc1)(C(=O)O)[N+](=O)[O-]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.41
HIF1A Q16665 1/20 0.41
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41
CA2 P00918 2/20 0.40
ESR1 P03372 2/20 0.40
CAMK2A Q9UQM7 1/20 0.40
SLC7A5 Q01650 1/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
USP2 O75604 1/20 0.37
EGFR P00533 1/20 0.37
CYP1A2 P05177 1/20 0.37
FYN P06241 1/20 0.37
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3891311 1.00 BLM (0.56) BLMSMN1; SMN2HIF1AFNTAFNTB
SCHEMBL14935688 0.86 SMN1; SMN2 (0.56) BLMSMN1; SMN2HIF1ACYP1A2CYP3A4
SCHEMBL28243868 0.86 SMN1; SMN2 (0.56) BLMSMN1; SMN2HIF1ACYP1A2CYP3A4
SCHEMBL4362988 0.86 SMN1; SMN2 (0.56) BLMSMN1; SMN2HIF1ACYP1A2CYP3A4
SCHEMBL7387615 0.74 BLM (0.67) BLMSMN1; SMN2HIF1AFNTAFNTB
SCHEMBL7795287 0.73 SMN1; SMN2 (0.49) BLMSMN1; SMN2HIF1ASLC7A5ALDH1A1
SCHEMBL28664390 0.73 BLM (0.44) BLMFNTAFNTBCA2ESR1
SCHEMBL28966331 0.73 BLM (0.65) BLMSMN1; SMN2HIF1AFNTAFNTB
SCHEMBL17768418 0.73 BLM (0.65) BLMSMN1; SMN2HIF1AFNTAFNTB
SCHEMBL24253146 0.72 BLM (0.62) BLMSMN1; SMN2HIF1AFNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200222492-A1 Method of Reducing Injury to Mammalian Cells NONO INC. (CA) 2020-07-16 US disclosed
US-20180369319-A1 Method of Reducing Injury to Mammalian Cells NONO INC (CA) 2018-12-27 US disclosed
US-20170239316-A1 Method Of Reducing Injury To Mammalian Cells NONO INC (CA) 2017-08-24 US disclosed
US-20150190459-A1 Method Of Reducing Injury To Mammalian Cells NONO INC (CA) 2015-07-09 US disclosed
US-20120302504-A1 Method Of Reducing Injury To Mammalian Cells NONO, INC. (CA) 2012-11-29 US disclosed
US-8071548-B2 Method of reducing injury to mammalian cells NONO, INC. (CA) 2011-12-06 US disclosed
US-20090281037-A1 Method of Reducing Injury to Mammalian Cells NONO INC. (CA) 2009-11-12 US disclosed
US-7510824-B2 Method of screening peptides useful in treating traumatic injury to the brain or spinal cord NONO INC. (CA) 2009-03-31 US disclosed
US-20050059597-A1 Method of reducing injury to mammalian cells 2056954 ONTARIO LTD. (CA) 2005-03-17 US disclosed